Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 14 (2023)
      • Volume 14 – Issue 1
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: lipoproteins

Lipid markers, gender and cardiovascular disease; Highlights from the ATTICA prospective epidemiological study (2002-2012)

Matina Kouvari, Demosthenes B. Panagiotakos, Christina Chrysohoou, Ekavi N. Georgousopoulou, Dimitrios Tousoulis, Christos Pitsavos, The ATTICA study Investigators

Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities

Eleni A. Karavia, Kyriakos E. Kypreos

Lipid control in patients with and without type 2 Diabetes Mellitus (T2DM). The experience of a special unit of a second grade hospital

Stamatis S Papadatos, Adamantios Bourdakis

HDL as a transporter of microRNAs in plasma: potential pathophysiolocal role

A. I. Gatsiou, K. Stellos, A. D. Tselepis

CURRENT ISSUE

Prof Moses Elisaf
The health benefits of olive oil in cardiovascular disease prevention: An update
Test-retest Repeatability; Integrated assessment of adherence to treatment questionnaire for Cardiometabolic Diseases
Erectile dysfunction and its correlation with arterial hypertension and cardiovascular diseases
Polygenic risk scores and personalized approaches to cardiometabolic disease prevention and treatment: A short review

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (4) cardiovascular disease (25) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (6) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (5) dyslipidemia (14) epidemiology (3) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (8) inflammation (10) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (8) metabolic syndrome (7) mortality (8) non-alcoholic fatty-liver disease (4) obesity (8) outcome (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) risk factors (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombosis (4) treatment (5) type 2 diabetes (3) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme